Allergan says rivals using trade secrets disclosed by USITC order
13-08-2019
Swiss court mulls extradition of Chinese researcher accused of GSK trade secrets theft
10-07-2019
Pavel Kapysh / Shutterstock.com
Cannabinoid maker Lavvan has filed a $881 million trade secrets lawsuit against pharmaceutical company Amyris.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Lavvan, Amyris, John Melo, cannabinoid, IP, trade secrets, RCL
